Abraxane and blood bilirubin increased Patient Reports February 11, 2012

Abraxane Side Effects Report #5200266-4
Abraxane side effect was reported by a Physician from UNITED STATES on Dec 21, 2006. Female patient, 66 years of age, weighting 207.0 lb, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: blood bilirubin increased, febrile neutropenia, neutropenic sepsis, respiratory failure. Abraxane dosage: RECEIVED ONE DOSE/520 MG (260 MG/M2), INTRAVENOUS. During the same period patient was treated with AVANDIA, AMARYL, COREG, PROCARDIA, METFORMIN, XALATAN, COLACE. Patient was hospitalized. Patient died on 10/19/2006.

Abraxane Side Effects Report #5091565-8
Abraxane side effect was reported by a Health Professional from UNITED STATES on Aug 17, 2006. Female patient, 66 years of age, weighting 163.0 lb, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: alpha haemolytic streptococcal infection, aspartate aminotransferase increased, asthenia, blood albumin decreased, blood bilirubin increased, blood glucose increased, disease progression, fatigue, liver function test abnormal. Abraxane dosage: 470 MG ONCE (260 MG/M2,X1), INTRAVENOUS DRIP. During the same period patient was treated with VICODIN, XELODA, EFFEXOR, SOTALOL, LEVOTHYROXINE, DIGOXIN, ACTOS, ELAVIL. Patient was hospitalized. Patient died on 03/26/2006.

Abraxane Side Effects Report #4820665-X
Abraxane side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 14, 2005. Female patient, 66 years of age, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, alpha haemolytic streptococcal infection, aspartate aminotransferase increased, asthenia, blood albumin decreased, blood bilirubin increased, blood culture positive, blood glucose increased, fatigue. Abraxane dosage: 470 MG (260 MG/M2 EVERY 3 WEEKS). During the same period patient was treated with VICODIN, XELODA, EFFEXOR, SOTALOL, LEVOTHYROXINE, DIGOXIN, ACTOS, ELAVIL. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #4820962-8
Abraxane side effect was reported by a Health Professional from UNITED STATES on Oct 14, 2005. Female patient, 66 years of age, weighting 163.0 lb, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: albumin globulin ratio decreased, aspartate aminotransferase increased, asthenia, blood albumin decreased, blood bilirubin increased, blood glucose increased, candidiasis, fatigue, globulins decreased. Abraxane dosage: 470 MG (20 MG/M2, EVERY 3 WEEKS), INTRAVENOUS DRIP. During the same period patient was treated with VICODIN, XELODA, EFFEXOR, SOTALOL, LEVOTHYROXINE, DIGOXIN, ACTOS, ELAVIL. Patient was hospitalized. Patient recovered.


Abraxane Side Effects Report #6009136-5
Abraxane side effect was reported by a Physician from UNITED STATES on Dec 04, 2008. Female patient, 62 years of age, weighting 310.0 lb, was diagnosed with breast cancer metastatic, hypertension and was treated with Abraxane. After drug was administered, patient experienced the following side effects: arthralgia, blood bilirubin increased, blood calcium decreased, blood pressure diastolic decreased, blood sodium decreased, carbon dioxide decreased, constipation , dehydration, haematocrit decreased. Abraxane dosage: (125 MG/M2, 9 WEEK). During the same period patient was treated with NEXAVAR, HYDROCHLOROTHIAZIDE, MOBIC, VISTERIL, LORTAB, VITAMIN, CALCIUM. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #6094812-9
Abraxane side effect was reported by a Physician from UNITED STATES on Feb 10, 2009. Female patient, 62 years of age, weighting 310.0 lb, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: arthralgia, aspartate aminotransferase increased, bacteraemia, blood bilirubin increased, blood calcium decreased, blood pressure diastolic decreased, blood sodium decreased, constipation , dehydration. Abraxane dosage: 125 MG/M2, 9 WEEK. During the same period patient was treated with NEXAVAR, HYDROCHLOROTHIAZIDE, MOBIC, VISTERIL, LORTAB, VITAMIN, CALCIUM, FLEXERIL. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #5916732-X
Abraxane side effect was reported by a Physician from UNITED STATES on Sept 24, 2008. Female patient, 55 years of age, weighting 196.2 lb, was diagnosed with breast cancer metastatic and was treated with Abraxane. After drug was administered, patient experienced the following side effects: abdominal pain lower, alanine aminotransferase increased, aspartate aminotransferase increased, atelectasis, blood alkaline phosphatase increased, blood bilirubin increased, blood creatinine increased, blood culture positive, blood lactic acid increased. Abraxane dosage: (291 MG), INTRAVENOUS. During the same period patient was treated with GEMZAR, AVASTIN. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #5319046-4
Abraxane side effect was reported by a Physician from UNITED STATES on Apr 16, 2007. Female patient, 59 years of age, weighting 319.7 lb, was diagnosed with breast cancer  and was treated with Abraxane. After drug was administered, patient experienced the following side effects: blood bilirubin increased, dehydration, mucosal inflammation, pain , pharyngolaryngeal pain. Abraxane dosage: unknown. Patient was hospitalized. Patient recovered.

Abraxane Side Effects Report #5325859-5
Abraxane side effect was reported by a Physician from UNITED STATES on Apr 25, 2007. Female patient, 59 years of age, weighting 145.0 lb, was diagnosed with breast cancer  and was treated with Abraxane. After drug was administered, patient experienced the following side effects: blood bilirubin increased, dehydration, leukopenia, liver function test abnormal, mucosal inflammation, pain , pharyngolaryngeal pain. Abraxane dosage: LAST DOSE PRIOR TO SAE (CYCLE 2, 110 MG/M2) , INTRAVENOUS. Patient was hospitalized. Patient recovered.


Abraxane Side Effects Report #5074881-5
Abraxane side effect was reported by a Physician from UNITED STATES on July 21, 2006. Female patient, 48 years of age, was diagnosed with breast cancer  and was treated with Abraxane. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bile duct obstruction, blood albumin decreased, blood alkaline phosphatase increased, blood bilirubin increased, blood calcium decreased, blood creatinine decreased, blood sodium decreased. Abraxane dosage: unknown. During the same period patient was treated with AVASTIN, NEXIUM, RISPERDAL. Patient recovered.